Press

Aethryva Deeptech Pvt Ltd is creating a new category of ICU intelligence. The company's flagship product, PriyAI Sentinel, is the world's first full-stack bedside device designed for continuous multi-organ trajectory computation and real-time intervention timing prediction.

Powered by a proprietary computational framework (KAE · MOISS) and an open-source biomedical programming language (MOISSCode), PriyAI Sentinel represents a fundamental shift from reactive threshold-based alerts to predictive, timing-aware critical care.

PriyAI Sentinel is not a monitor upgrade. It is the first bedside device engineered for continuous biochemical sensing, multi-organ trajectory computation, and real-time intervention timing. This device category did not exist before. Aethryva is creating it.

The intellectual property estate spans 7 patents across 4 domains: microfluidic biochemical sensing hardware, adaptive estimation algorithms (KAE), multi-organ staging protocols (MOISS), and a domain-specific biomedical programming language (MOISSCode) — released open-source on GitHub.